U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)

Agency/Department

FLC Region

Security Lab

No

Address

1520 Freedman Drive, Rm 227
Fort Detrick, MD 21702-5012
United States

Laboratory Representative

(P)

(301) 619-4145

Description

The U.S. Army Medical Research and Development Command (USAMRDC) is the Army's medical materiel developer. The Command has four major Core Capabilities:

  • Shape future medical solutions through research, advanced technology, and partnerships;
  • Execute streamlined medical logistics, facilities and acquisition management;
  • Develop, integrate, acquire and sustain medical IM/IT solutions; and
  • Provide best business and program management solutions.

Mission

The USAMRDC is the executive or lead agency responsible for:

  • Military Human Immunodeficiency Virus (HIV) R&D Program (Acquired Immune Deficiency Syndrome (AIDS))
  • Military Infectious Diseases Research Program (MIDRP)
  • Global Emerging Infections Surveillance and Response System (GEIS)
  • Use of Investigational New Drugs for Force Health Protection
  • DOD Food and Nutrition Research, Development, Test, Evaluation, and Engineering Program
  • Combat Dentistry Research Program
  • Gulf War Illnesses/Force Health Protection Research Program
  • Peer Reviewed Medical Research Program (PRMRP)

The USAMRDC's expertise in these critical areas helps establish and maintain the capabilities required by the Army to fight and win on the battlefield.

Technology Disciplines

Technologies
Displaying 1 - 10 of 14
 
Body Cooling System (BCS)
Chew Plaktak™ Gum to Prevent Plaque
Cold Weather Ensemble Decision Aid (CoWEDA)
Estimation of Human Core Temperature Based on Heart Rate System and Method (EC Temp)
Glare Testing Device
Intravenous Omega-3 Fatty Acid Compositions for Treatment of Traumatic Brain Injury
Long Lasting Protection Against G-Type Nerve Agents
Method and System for Measuring, Predicting, and Optimizing Cognitive Performance (“2B-Alert")
Personal Water and Additive Apparatus (Nutrient Delivery System)
Plasma-Alginate Composite Gel Matrix

Pages

Facilities

No Facilities

Equipment

No Equipment

Programs

No Programs

Funds

No Funds

Publications

No Publications

Successes

No Successes

Licenses
Agency
U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)
Action:
Intent
Publication DateAug 25, 2020

In accordance with applicable laws and regulations, the Department of the Army hereby gives notice of its intent to grant a partially exclusive, royalty-bearing, revocable license.

Dates:
Written objections must be filed not later than 15 days following the publication of this announcement.
Address:
Send written objections to Commander, U.S. Army Medical Research and Development Command, ATTN: Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012
For further information contact:

Mr. Paul Michaels, Office of Research and Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.

Supplementary information:

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant a partially exclusive, royalty-bearing, revocable license to United States Patent Application Serial No. 16/327,846 filed on February 24, 2019, from PCT Application No. PCT/US2017/047547, entitled “Real-Time Estimation of Human Core Body Temperature Based on Non-Invasive Physiological Measurements,” and a continuation patent application thereof, to Seaclaid, LLC, a limited-liability company having its principal place of business at 7593 Fenway Rd, New Albany, OH 43054.

Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES).

Correction:
Send Inquiry
Agency
U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)
Action:
Intent
Publication DateMar 20, 2020

In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license.

Dates:
March 20, 2020
Address:
Commander, U.S. Army Medical Research and Development Command, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012.
For further information contact:

Mr. Paul Michaels, Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.

Supplementary information:

In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license to United States Patent 9,675,572, filed April 22, 2011, entitled “Intravenous Omega-3 Fatty Acid Compositions and Methods of Use” to Deck Therapeutics Inc. having its principal place of business at 180 Varick Street, 6th Floor, New York, NY 10014.
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see ADDRESSES).

Correction:
Send Inquiry
Agency
U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)
Action:
Intent
Publication DateDec 13, 2019

In accordance with applicable
laws and regulations, announcement is
made of the intent to grant an exclusive
within a field of use, royalty-bearing,
revocable patent license.

Dates:
Notice submitted 12/13/2019
Address:
Commander, U.S. Army Medical Research and Development Command, ATTN: Medical Technology Transfer Office, FCMR–ZCT, 504 Scott Street, Fort Detrick, MD 21702–5012
For further information contact:

Dr. Paul G. Michaels, eJD, Medical Technology
Transfer Office, (301) 619–4145

Supplementary information:

In accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i), announcement is
made of the intent to grant an exclusive
within a field of use, royalty-bearing,
revocable license of US Patent No. 10,058,448 B2
entitled “Arm Immersion Cooling
Apparatus and Method”, issued on August 28, 2018 to First Line Technology
LLC, having its principal place of business at
3656 Centerview Drive, Suite 4, Chantilly,
Virginia 20151.

Correction:
Send Inquiry
Agency
U.S. Army Medical Research & Development Command - Medical Technology Transfer Office (MTT)
Action:
Intent
Publication DateDec 06, 2019

In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license.

Dates:
Notice Submitted 6 December 2019.
Address:
Commander, U.S. Army Medical Research and Development Command, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012
For further information contact:

Mr. Paul Michaels, Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.

Supplementary information:

In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license to United States Patent 7,494,980, filed March 9, 2004, entitled “Antimicrobial Peptide and Methods of Use Thereof” and United States Patent 8,778,889, filed on October 18, 2006, entitled “Antimicrobial Decapeptide Oral Hygiene Treatment” to P4 Microbiome, Inc. having its principal place of business at 20271 Goldenrod Lane, Suite 2046, Germantown, MD 20876.

Correction:
Send Inquiry